Nurea
Founded 2018 · 17 employees on LinkedIn · 2 known investors
Find your way into Nurea
Sign up to see every warm intro you have to Nurea
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nurea team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nurea develops medical imaging software that automatically reconstructs and analyzes the arterial tree from DICOM CT scans to support the diagnosis and follow-up of vascular diseases such as aortic aneurysms. Its tools are designed for physicians and integrate with existing PACS, workstations, and imaging software.
Investors · 2
Newfund Capitallisted by Newfund CapitalParis · $250K – $2M
How we know: Newfund Capital's portfolio page · Not right? Tell us
StartXlisted by StartXStanford · $10K – $1M
How we know: StartX's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Nurea do?
- Nurea develops medical imaging software that automatically reconstructs and analyzes the arterial tree from DICOM CT scans to support the diagnosis and follow-up of vascular diseases such as aortic aneurysms. Its tools are designed for physicians and integrate with existing PACS, workstations, and imaging software.
- Who are Nurea's investors?
- Nurea's investors include Newfund Capital, StartX.


